Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase NA 12Phase 4 9Phase 3 4Phase 2/3 4Phase 1/2 4Phase 1 3

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 2NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2CNS 1

Conditions

Uterine Cervical Neoplasms 1Recurrence 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Meningeal Carcinomatosis 1Insulin Resistance 1Infertility 1Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Folic Acid × Clear all
NCT05289908 2025-05-04

Intrathecal Pemetrexed for Leptomeningeal Metastasis

The First Hospital of Jilin University

Phase 1/2 Completed
34 enrolled
CNS

Meningeal Carcinomatosis

NCT01188876 2018-01-19

Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer

Massachusetts General Hospital

Phase 1/2 Completed
50 enrolled 15 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT03268733 2017-08-31

FolicacidPCOS

University of Khartoum

Phase 1/2 Unknown
90 enrolled

Infertility, Insulin Resistance, Polycystic Ovary Syndrome

NCT00220532 2006-09-13

Folate and Protection Against Cervical Cancer

Sheffield Teaching Hospitals NHS Foundation Trust

Phase 1/2 Terminated
180 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡